New method for breast cancer screening using low-field MRI technology
Novel technique for breast cancer screening and evaluation using ultra low field MRI
This study is exploring a new way to check for breast cancer using a special type of MRI that is gentle and doesn't use radiation, making it more comfortable for women, especially those with dense breast tissue, while aiming to provide clearer pictures to help spot any issues more accurately.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10525576 on NIH RePORTER |
What this research studies
This research investigates a novel approach to breast cancer screening using ultra-low field magnetic resonance imaging (MRI). Unlike traditional mammography, which can be uncomfortable and less effective for women with dense breast tissue, this technique does not require compression or involve radiation. The study aims to utilize quantitative MRI measurements to create detailed maps of breast tissues, helping to distinguish between healthy and malignant tissues more effectively. By addressing the limitations of current screening methods, this research seeks to improve accessibility and accuracy in breast cancer detection.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who have dense breast tissue or those who have experienced anxiety or discomfort with traditional mammography.
Not a fit: Patients who have already been diagnosed with breast cancer or those who do not have breast tissue may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more accurate and comfortable breast cancer screening method, potentially increasing early detection rates.
How similar studies have performed: Previous research has shown promise in using MRI for breast cancer detection, but this specific ultra-low field approach is relatively novel and untested.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Rosen, Matthew Scot — Massachusetts General Hospital
- Study coordinator: Rosen, Matthew Scot
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.